Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Mu Opioid Receptor 1 anticorps (Extracellular, N-Term)

OPRM1 Reactivité: Humain, Souris, Rat WB, IHC, IF, ICC, LCI Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7043403
  • Antigène Voir toutes Mu Opioid Receptor 1 (OPRM1) Anticorps
    Mu Opioid Receptor 1 (OPRM1) (Opioid Receptor, mu 1 (OPRM1))
    Épitope
    • 27
    • 7
    • 7
    • 6
    • 6
    • 5
    • 5
    • 5
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 22-38, Extracellular, N-Term
    Reactivité
    • 56
    • 42
    • 19
    • 5
    • 5
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain, Souris, Rat
    Hôte
    • 71
    • 3
    • 2
    Lapin
    Clonalité
    • 75
    • 1
    Polyclonal
    Conjugué
    • 37
    • 7
    • 6
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Mu Opioid Receptor 1 est non-conjugé
    Application
    • 57
    • 32
    • 30
    • 15
    • 14
    • 13
    • 5
    • 5
    • 4
    • 4
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC), Live Cell Imaging (LCI)
    Attributs du produit
    Anti-μ-Opioid Receptor (OPRM1) (extracellular) Antibody (ABIN7043403, ABIN7044887 and ABIN7044888)) is a highly specific antibody directed against an epitope of the rat protein. The antibody can be used in western blot, immunohistochemistry, live cell imaging, and indirect live cell flow cytometry applications. It has been designed to recognize MOR-1 from rat, human, and mouse samples.
    Purification
    Affinity purified on immobilized antigen.
    Immunogène

    Immunogen: Synthetic peptide

    Immunogen Sequence: CSPAPGSWLNLSHVDGN, corresponding to amino acid residues 22-38 of the rat mu-Opioid receptor

    Isotype
    IgG
    Top Product
    Discover our top product OPRM1 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.
    Concentration
    0.8 mg/mL
    Buffer
    Reconstituted antibody contains phosphate buffered saline (PBS), pH 7.4, 1 % BSA, 0.05 % Sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    RT,4 °C,-20 °C
    Stockage commentaire

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Antigène
    Mu Opioid Receptor 1 (OPRM1) (Opioid Receptor, mu 1 (OPRM1))
    Autre désignation
    mu-Opioid Receptor (OPRM1) (OPRM1 Produits)
    Synonymes
    anticorps LMOR, anticorps M-OR-1, anticorps MOP, anticorps MOR, anticorps MOR1, anticorps OPRM, anticorps MOP-R, anticorps MOR-1, anticorps MOR-1O, anticorps Oprm, anticorps mor, anticorps muOR, anticorps MORA, anticorps Oprrm1, anticorps or2, anticorps ZFOR2, anticorps OPRM1, anticorps opioid receptor mu 1, anticorps opioid receptor, mu 1, anticorps outer membrane protein OprM, anticorps OPRM1, anticorps Oprm1, anticorps oprm1, anticorps oprM1
    Sujet
    Alternative names: mu-Opioid Receptor (OPRM1), Mu-type opioid receptor, Opioid receptor B, MOR-1, MOP, Mu-opiate receptor
    ID gène
    25601
    NCBI Accession
    NM_000914
    UniProt
    P33535
    Pathways
    cAMP Metabolic Process, Synaptic Membrane
Vous êtes ici: